Car Sales Still Spe...
Health Care: Drugs
Accelr8 Technology Corporation (AXK: AMEX)
$3.48 0.81 | 30.34%
06/01/12 - 04:03 PM ET
Company Income Statement
| Jul 2011 | Jul 2010 | Jul 2009 | Jul 2008 | |
| Sales | 1.12M | 2.25M | 1.27M | 475.52K |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 9.65K |
| Gross Operating Profit | 1.12M | 2.25M | 1.27M | 465.87K |
| Selling, General, and Administrative Expenses | 819.70K | 870.75K | 932.99K | 1.02M |
| Research & Development | 455.00K | 501.60K | 745.93K | 880.98K |
| Operating Income before D & A (EBITDA) | -153.53K | 873.28K | -409.03K | -1.43M |
| Depreciation & Amortization | 255.90K | 261.49K | 270.09K | 294.23K |
| Interest Income | 16.09K | 6.05K | 18.33K | 63.08K |
| Other Income - Net | 14.57K | 23.90K | -53.41K | -15.79K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -378.76K | 641.75K | -714.20K | -1.68M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -378.76K | 641.75K | -714.20K | -1.68M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -378.76K | 641.75K | -714.20K | -1.68M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -378.76K | 641.75K | -714.20K | -1.68M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -378.76K | 641.75K | -714.20K | -1.68M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-378.76K | 641.75K | -714.20K | -1.68M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -378.76K | 641.75K | -714.20K | -1.68M |
| Basic EPS from Continuing Ops. | -0.04 | 0.06 | -0.07 | -0.17 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.04 | 0.06 | -0.07 | -0.17 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.04 | 0.06 | -0.07 | -0.17 |
| Basic Normalized Net Income/Share | -0.04 | 0.06 | -0.07 | -0.17 |
| EPS fr Continuing Ops. | -0.04 | 0.06 | -0.07 | -0.17 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.04 | 0.06 | -0.07 | -0.17 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.04 | 0.06 | -0.07 | -0.17 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.04 | 0.06 | -0.07 | -0.17 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with AXK
- Portfolio NameUser Type
- ContributorBest-Performing Stocks Unde...
- Contributor10 Best-Performing Stocks U...
- Contributor10 Best-Performing Stocks U...
- UserMary
- UserBerridge Investments
- Userlaredo Portfolio 1
- Usergenomiks BIOMED
- UserPANTERA GROUP 169(SUPRATRADE)
- UserBenitrans GStock II
- UserCharles
Latest AXK Headlines from TheStreet
- Accelr8 Technology Corporation Stock Downgraded (AXK) 11.02.11 | 07:11 am
- Accelr8 Technology Stock Soars (AXK) 10.12.11 | 10:10 am
- Accelr8 Technology Stock Soars (AXK) 10.05.11 | 02:10 pm
- Best-Performing Stocks Under $5 in 2011 09.28.11 | 01:09 pm
- Best-Performing Stocks Under $5 in 2011 08.31.11 | 06:08 am
- Accelr8 Technology Stock Gaps Up On Today's Open (AXK) 06.30.11 | 10:06 am
- Accelr8 Technology Stock Soars (AXK) 06.22.11 | 02:06 pm
- Accelr8 Technology Stock Soars (AXK) 06.09.11 | 10:06 am
- 10 Best-Performing Stocks Under $5 This Year 04.27.11 | 06:04 am
- 10 Best-Performing Stocks Under $5 This Year 03.30.11 | 07:03 am
Press Releases for AXK
- Accelr8 Attracts Up To $35 Million Private Equity Investment - Business Wire 04.23.12 | 03:04 pm
- Accelr8 Announces Interim Plan And Advanced Studies - Business Wire 10.13.11 | 07:10 am
- Accelr8 Announces Renewal And Expansion Of SCHOTT Microarray License, And Notice Of Allowance For New Patent - Business Wire 09.22.11 | 08:09 am
- Accelr8 Announces Results In Award-Winning Presentation For Rapid Diagnostics With ICU Specimens - Business Wire 09.19.11 | 10:09 am
- Accelr8 Announces Continuation And Expansion Of BACcel™ Development Collaboration - Business Wire 07.25.11 | 08:07 am
- Accelr8 To Receive Award For ICAAC Presentation - Business Wire 07.18.11 | 07:07 am
- Accelr8 Announces Continuation Of BACcel™ Collaboration - Business Wire 06.30.11 | 05:06 pm
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 06.09.11 | 11:06 am
- Accelr8 4-Hour Test Identifies New Drug-Resistant “Staph” (hVISA) Undetectable By Hospital Labs - Business Wire 05.23.11 | 07:05 am
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 05.19.11 | 05:05 pm
Partner Headlines for AXK
- Accelr8 Technology Corp: Invest At Your Own Risk - Seeking Alpha 06.24.11 | 09:06 am
